A Highly Sensitive Liquid Chromatography–Electrospray Ionization–Time of Flight/Mass Spectrometric Assay for the Quantitation of 4-Beta-Hydroxycholesterol and Its Application to in vivo Cytochrome P450 3a Induction by AGM-130

References

• Bodin, K.; Bretillon, L.; Aden, Y.; Bertilsson, L.; Broome, U.; Einarsson, C.; Diczfalusy, U. Antiepileptic Drugs Increase Plasma Levels of 4beta-Hydroxycholesterol in Humans: Evidence for Involvement of Cytochrome p450 3A4. J. Biol. Chem. 2001, 276 (42), 38685–38689.
   PubMed Web of Science ®Google Scholar
• Diczfalusy, U.; Nylen, H.; Elander, P.; Bertilsson, L. 4beta-Hydroxycholesterol, an Endogenous Marker of CYP3A4/5 Activity in Humans. Brit. J. Clin. Pharmacol. 2011, 71 (2), 183–189.
   PubMed Web of Science ®Google Scholar
• Li, A. P.; Kaminski, D. L.; Rasmussen, A. Substrates of Human Hepatic Cytochrome P450 3A4. Toxicology 1995, 104 (1–3), 1–8.
   PubMed Web of Science ®Google Scholar
• Kanebratt, K. P.; Diczfalusy, U.; Backstrom, T.; Sparve, E.; Bredberg, E.; Bottiger, Y.; Andersson, T. B.; Bertilsson, L. Cytochrome P450 Induction by Rifampicin in Healthy Subjects: Determination Using the Karolinska Cocktail and the Endogenous CYP3A4 Marker 4beta-hydroxycholesterol. Clin. Pharmacol. Ther. 2008, 84 (5), 589–594.
   PubMed Web of Science ®Google Scholar
• Gebeyehu, E.; Engidawork, E.; Bijnsdorp, A.; Aminy, A.; Diczfalusy, U.; Aklillu, E. Sex and CYP3A5 Genotype Influence Total CYP3A Activity: High CYP3A Activity and a Unique Distribution of CYP3A5 Variant Alleles in Ethiopians. Pharmacogenom. J. 2011, 11 (2), 130–137.
   PubMed Web of Science ®Google Scholar
• Xu, Y.; Yuan, Y.; Smith, L.; Edom, R.; Weng, N.; Mamidi, R.; Silva, J.; Evans, D. C.; Lim, H. K. LC-ESI-MS/MS Quantification of 4beta-hydroxycholesterol and Cholesterol in Plasma Samples of Limited Volume. J. Pharm. Biomed. Anal. 2013, 85, 145–154.
   PubMed Web of Science ®Google Scholar
• Dzeletovic, S.; Breuer, O.; Lund, E.; Diczfalusy, U. Determination of Cholesterol Oxidation Products in Human Plasma by isotope Dilution-Mass Spectrometry. Anal. Biochem. 1995, 225 (1), 73–80.
   PubMed Web of Science ®Google Scholar
• Goodenough, A. K.; Onorato, J. M.; Ouyang, Z.; Chang, S.; Rodrigues, A. D.; Kasichayanula, S.; Huang, S. P.; Turley, W.; Burrell, R.; Bifano, M.; Jemal, M.; LaCreta, F.; Tymiak, A.; Wang-Iverson, D. Quantification of 4-beta-hydroxycholesterol in Human Plasma Using Automated Sample Preparation and LC-ESI-MS/MS Analysis. Chem. Res. Toxicol. 2011, 24 (9), 1575–1585.
   PubMed Web of Science ®Google Scholar
• Honda, A.; Yamashita, K.; Hara, T.; Ikegami, T.; Miyazaki, T.; Shirai, M.; Xu, G.; Numazawa, M.; Matsuzaki, Y. Highly Sensitive Quantification of Key Regulatory Oxysterols in Biological Samples by LC-ESI-MS/MS. J. Lipid. Res. 2009, 50 (2), 350–357.
   PubMed Web of Science ®Google Scholar
• Huang, M. Q.; Lin, W.; Wang, W.; Zhang, W.; Lin, Z. J.; Weng, N. Quantitation of P450 3A4 Endogenous Biomarker - 4beta-hydroxycholesterol - in Human Plasma Using LC/ESI-MS/MS. Biomed. Chromatogr. BMC. 2014, 28 (6), 794–801.
   PubMed Web of Science ®Google Scholar
• Choi, S. J.; Lee, J. E.; Jeong, S. Y.; Im, I.; Lee, S. D.; Lee, E. J.; Lee, S. K.; Kwon, S. M.; Ahn, S. G.; Yoon, J. H.; Han, S. Y.; Kim, J. I.; Kim, Y. C. 5,5′-Substituted Indirubin-3′-oxime Derivatives as Potent Cyclin-dependent Kinase Inhibitors with Anticancer Activity. J. Med. Chem. 2010, 53 (9), 3696–3706.
   PubMed Web of Science ®Google Scholar
• Kim, W. S.; Lee, M. J.; Kim, D. H.; Lee, J. E.; Kim, J. I.; Kim, Y. C.; Song, M. R.; Park, S. G. 5′-OH-5-nitro-Indirubin Oxime (AGM130), an Indirubin Derivative, Induces Apoptosis of Imatinib-resistant Chronic Myeloid Leukemia Cells. Leukem. Res. 2013, 37 (4), 427–433.
   PubMed Web of Science ®Google Scholar
• Cadoo, K. A.; Gucalp, A.; Traina, T. A. Palbociclib: An Evidence-based Review of Its Potential in the Treatment of Breast Cancer. Breast Canc. 2014, 6, 123–133.
   PubMedGoogle Scholar
• Breuer, O. Identification and Quantitation of Cholest-5-ene-3 beta,4 beta-diol in Rat Liver and Human Plasma. J. Lipid Res. 1995, 36 (11), 2275–2281.
   PubMed Web of Science ®Google Scholar
• van de Merbel, N. C.; Bronsema, K. J.; van Hout, M. W.; Nilsson, R.; Sillen, H. A Validated Liquid Chromatography-Tandem Mass Spectrometry Method for the Quantitative Determination of 4beta-hydroxycholesterol in Human Plasma. J. Pharm. Biomed. Anal. 2011, 55 (5), 1089–1895.
   PubMed Web of Science ®Google Scholar
• Lutjohann, D.; Marinova, M.; Schneider, B.; Oldenburg, J.; von Bergmann, K.; Bieber, T.; Bjorkhem, I.; Diczfalusy, U. 4beta-hydroxycholesterol as a Marker of CYP3A4 Inhibition In Vivo - Effects of Itraconazole in Man. Int. J. Clin. Pharm. Therapeut. 2009, 47 (12), 709–715.
   PubMed Web of Science ®Google Scholar
• Guiding principles in the use of animals in toxicology. Adopted by the Society of Toxicology in July 1989. Toxicology and applied pharmacology 2002, 178 (1), 4p., https://www.toxicology.org/pubs/statements/Guiding_Principles.pdf.
   Google Scholar
• Silverman, J.; Baker, S. P.; Lidz, C. W. A self-assessment survey of the Institutional Animal Care and Use Committee, part 2: structure and organizational functions. Lab animal. 2012, 41 (10), 289–94.
   Web of Science ®Google Scholar